A

Ascendis Pharma A/S
D

ASND

137.890
USD
1.78
(1.31%)
Market Open
Volume
3,368
EPS
-8
Div Yield
-
P/E
-18
Market Cap
8,245,794,284
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    0.300
    (1.78%)
    17.170 USD
    AMP
    AMP
    1.32
    (0.25%)
    533.81 USD
    B
    BFS
    -0.220
    (-0.57%)
    38.430 USD
    C
    CF
    0.135
    (0.16%)
    85.095 USD
    ETN
    ETN
    -1.27
    (-0.38%)
    336.77 USD
    L
    LSXMA
    0
    (0%)
    0.000000 USD
    O
    OCFC
    -0.005
    (-0.03%)
    17.800 USD
    T
    TKR
    -0.535
    (-0.75%)
    71.155 USD
    More
News

Title: Ascendis Pharma A/S

Sector: Healthcare
Industry: Biotechnology
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.